Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Karyopharm Therapeutics (KPTI) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Karyopharm Therapeutics (KPTI) over the last 14 years, with Q4 2025 value amounting to $1.3 million.

  • Karyopharm Therapeutics' Treasury Shares rose 5559.36% to $1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 million, marking a year-over-year increase of 5559.36%. This contributed to the annual value of $1.3 million for FY2025, which is 5559.36% up from last year.
  • Latest data reveals that Karyopharm Therapeutics reported Treasury Shares of $1.3 million as of Q4 2025, which was up 5559.36% from $850738.0 recorded in Q4 2024.
  • Karyopharm Therapeutics' Treasury Shares' 5-year high stood at $7.7 million during Q4 2023, with a 5-year trough of $850738.0 in Q4 2024.
  • In the last 5 years, Karyopharm Therapeutics' Treasury Shares had a median value of $2.3 million in 2021 and averaged $3.1 million.
  • As far as peak fluctuations go, Karyopharm Therapeutics' Treasury Shares surged by 12529.59% in 2023, and later plummeted by 8890.31% in 2024.
  • Over the past 5 years, Karyopharm Therapeutics' Treasury Shares (Quarter) stood at $2.3 million in 2021, then surged by 47.91% to $3.4 million in 2022, then skyrocketed by 125.3% to $7.7 million in 2023, then crashed by 88.9% to $850738.0 in 2024, then surged by 55.59% to $1.3 million in 2025.
  • Its Treasury Shares stands at $1.3 million for Q4 2025, versus $850738.0 for Q4 2024 and $7.7 million for Q4 2023.